UNSPSC 51433931: Clevidipine butyrate

This classification denotes a calcium channel blocker with the molecular formula C21H23Cl2NO6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 19O2GP3B7Q, chemically known as 3,5-pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, methyl (1-oxobutoxy)methyl ester but more generally known as clevidipine, which bears US NIH Compound Identifier 153994. European Medicines Agency schedules Clevidipine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06655MIG.

UNSPSC 51433931 Clevidipine butyrate is a Commodity code representing pharmaceutical products for emergency medical use. State and local governments buy advanced life support medications — injectable medications for acute care and emergency response — under this code, typically through fire rescue departments, emergency medical services, and public health agencies. The City of Tampa's April 2026 bid for Advanced Life Support Medications illustrates the scope: sealed-bid procurement of specific injectable drugs (Labetalol, Epinephrine, Adenosine, Diltiazem) for use by Tampa Fire Rescue, with strict requirements for expiration dating, delivery timelines, product warranties, and regulatory compliance including OSHA Safety Data Sheets and WCAG accessibility standards. Issuing bodies include municipal fire rescue services and city purchasing departments acting as the procurement agent. The activity also shows state and local willingness to apply set-aside preferences — the Tampa solicitation includes a Small Local Business Enterprise sheltered-market designation with a 5 percent bid discount for SLBE participation, reflecting local vendor preference structures common in municipal procurement.

The code shows recent activity in Florida. The City of Tampa's Advanced Life Support Medications IFB (Solicitation 26P00188) closed April 8, 2026, with an estimated contract value of $40,000 and a one-year term with two optional renewals plus unilateral extension rights. No other recent state or local opportunities appear in the source block, suggesting limited recent posting activity under this specific commodity code or narrow vendor scope tied to specialized pharmaceutical supply chains for emergency response.